SuperworthChemed profit margin CHE
Gross, operating and net profit as a share of revenue over the last twelve months, from 2010.
- Net margin, 12 months
- 10.6%
- Operating margin, 12 months
- 13.5%
- Net margin on a year earlier
- −1.0 pts
- Peer median
- 6.5%
Over the twelve months to Jun 30, 2026, Chemed kept 10.6% of its revenue as net profit, with an operating margin of 13.5% and a gross margin of 33.1%.
Five years earlier its net margin was 14.3%.
The median for 10 hospital and care facility stocks of a similar size is 6.5%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 10.5% | 13.4% | 32.5% |
| FY2024 | 12.4% | 15.1% | 35.1% |
| FY2023 | 12.0% | 15.0% | 35.3% |
| FY2022 | 11.7% | 16.1% | 35.8% |
| FY2021 | 12.6% | 16.0% | 36.0% |
| FY2020 | 15.4% | 18.7% | 33.7% |
| FY2019 | 11.3% | 13.3% | 31.9% |
| FY2018 | 11.5% | 13.7% | 31.1% |
| FY2017 | 5.9% | 6.8% | 31.0% |
| FY2016 | 6.9% | 11.3% | 29.3% |
| FY2015 | 7.1% | 12.0% | 29.5% |
| FY2014 | 6.8% | 11.6% | 29.0% |
| FY2013 | 5.5% | 9.4% | 28.6% |
| FY2012 | 6.2% | 10.9% | 27.7% |
| FY2011 | 6.3% | 11.3% | 28.4% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 10.6% | −1.0 pts | 13.5% | |
| Q1 FY26 | 10.2% | −2.2 pts | 12.9% | |
| Q4 FY25 | 10.5% | −1.9 pts | 13.4% | |
| Q3 FY25 | 11.0% | −1.7 pts | 13.9% | |
| Q2 FY25 | 11.6% | −1.3 pts | 14.7% | |
| Q1 FY25 | 12.4% | +0.0 pts | 15.6% | |
| Q4 FY24 | 12.4% | +0.4 pts | 15.1% | |
| Q3 FY24 | 12.7% | +1.7 pts | 15.3% | |
| Q2 FY24 | 12.9% | +2.5 pts | 15.4% | |
| Q1 FY24 | 12.4% | +1.3 pts | 14.8% | |
| Q4 FY23 | 12.0% | +0.3 pts | 15.0% | |
| Q3 FY23 | 11.0% | −1.3 pts | 14.0% |
Against its peers
Companies in Medical - Care Facilities nearest Chemed's size, closest first, today.
| Company | Profit margin |
|---|---|
| CHEChemed | 10.6% |
| PACSPACS | 4.8% |
| SHCSotera Health | 13.4% |
| CONConcentra Group Holdings Parent | 8.7% |
| LFSTLifeStance Health | 3.2% |
| OPCHOption Care Health | 3.7% |
| ENSGEnsign | 6.9% |
| UHSUniversal Health Services | 8.4% |
| DVADavita | 6.0% |
| BTSGBrightSpring Health Services | 2.5% |
| NHCNational Healthcare | 9.0% |
| Peer median | 6.5% |
Where Chemed ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Chemed
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.